HIGHLIGHTS
- who: DIPG (diffuse intrinsic pontine and collaborators from the University of Leeds, United Kingdom have published the research work: Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical bene t, in the Journal: (JOURNAL)
- what: Despite exponential growth in our understanding of the mechanisms that drive pHGGs, patient outcomes remain unacceptably poor.
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- future: More work is desperately needed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.